Case Report: Long-term survival with erlotinib for lung cancer with secondary leptomeningeal carcinomatosis
{{output}}
Erlotinib is an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, effective as treatment for advanced non-small cell lung cancer; however, no quality evidence of its benefit in leptomeningeal carcinomatosis has been reported. Previous case ser... ...
